177 related articles for article (PubMed ID: 22710747)
1. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.
Epstein MM; Andrén O; Kasperzyk JL; Shui IM; Penney KL; Fall K; Rider JR; Stampfer MJ; Andersson SO; Giovannucci E; Mucci LA
Cancer Causes Control; 2012 Aug; 23(8):1359-66. PubMed ID: 22710747
[TBL] [Abstract][Full Text] [Related]
2. Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies.
Ma R; Gu Y; Zhao S; Sun J; Groome LJ; Wang Y
Am J Physiol Endocrinol Metab; 2012 Oct; 303(7):E928-35. PubMed ID: 22871339
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral Sterol-27-Hydroxylase (
Khan NA; Stopsack KH; Allott EH; Gerke T; Giovannucci EL; Mucci LA; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1052-1058. PubMed ID: 30867220
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D pathway gene variants and prostate cancer risk.
Holt SK; Kwon EM; Peters U; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1929-33. PubMed ID: 19454612
[TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
Clendenen TV; Ge W; Koenig KL; Axelsson T; Liu M; Afanasyeva Y; Andersson A; Arslan AA; Chen Y; Hallmans G; Lenner P; Kirchhoff T; Lundin E; Shore RE; Sund M; Zeleniuch-Jacquotte A
PLoS One; 2015; 10(10):e0140478. PubMed ID: 26488576
[TBL] [Abstract][Full Text] [Related]
7. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers.
Agic A; Xu H; Altgassen C; Noack F; Wolfler MM; Diedrich K; Friedrich M; Taylor RN; Hornung D
Reprod Sci; 2007 Jul; 14(5):486-97. PubMed ID: 17913968
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic variations in the vitamin D pathway with susceptibility to tuberculosis in Kazakhstan.
Sadykov M; Azizan A; Kozhamkulov U; Akilzhanova A; Yerezhepov D; Salfinger M; Chan CK
Mol Biol Rep; 2020 Mar; 47(3):1659-1666. PubMed ID: 31933264
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract.
Blomberg Jensen M; Nielsen JE; Jørgensen A; Rajpert-De Meyts E; Kristensen DM; Jørgensen N; Skakkebaek NE; Juul A; Leffers H
Hum Reprod; 2010 May; 25(5):1303-11. PubMed ID: 20172873
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D pathway regulatory genes encoding 1α-hydroxylase and 24-hydroxylase are dysregulated in sinonasal tissue during chronic rhinosinusitis.
Christensen JM; Cheng J; Earls P; Gunton J; Sewell W; Sacks R; Harvey RJ
Int Forum Allergy Rhinol; 2017 Feb; 7(2):169-176. PubMed ID: 27618536
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D pathway gene polymorphisms, vitamin D level, and cytokines in children with type 1 diabetes.
Tangjittipokin W; Umjai P; Khemaprasit K; Charoentawornpanich P; Chanprasert C; Teerawattanapong N; Narkdontri T; Santiprabhob J
Gene; 2021 Jul; 791():145691. PubMed ID: 33961971
[TBL] [Abstract][Full Text] [Related]
16. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer.
McCullough ML; Bostick RM; Mayo TL
Annu Rev Nutr; 2009; 29():111-32. PubMed ID: 19400699
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.
Simon KC; Munger KL; Xing Yang ; Ascherio A
Mult Scler; 2010 Feb; 16(2):133-8. PubMed ID: 20007432
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
[TBL] [Abstract][Full Text] [Related]
20. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
